Effect of BRAF and MEK inhibition in KRAS mutant NSCLC cell line NCI-H358
RNA-seq (gene expression) · human · 32 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Topic
- Lung cancerThis series is part of our curated briefing on it.
- Samples
- 32 samples: 8 conditions, mostly with about 4 replicates eachGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- RAF inhibitors activate the integrated stress response by direct activation of GCN2Nature communications · 2025
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE271504_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1131840 and SRA study SRP518030. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 32 samples.
How we read this: 8 replicated groups read from 32 sample titles; they account for 32 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8378094 NCI-H358 cells, DMSO, 4 hours, rep1 NCI-H358 cells, DMSO, 4…
- GSM8378095 NCI-H358 cells, DMSO, 4 hours, rep2 NCI-H358 cells, DMSO, 4…
- GSM8378096 NCI-H358 cells, DMSO, 4 hours, rep3 NCI-H358 cells, DMSO, 4…
- GSM8378097 NCI-H358 cells, DMSO, 4 hours, rep4 NCI-H358 cells, DMSO, 4…
- GSM8378098 NCI-H358 cells, 1uM dabrafenib, 4 hours, rep1 NCI-H358 cells, 1uM dab…
- GSM8378099 NCI-H358 cells, 1uM dabrafenib, 4 hours, rep2 NCI-H358 cells, 1uM dab…
- GSM8378100 NCI-H358 cells, 1uM dabrafenib, 4 hours, rep3 NCI-H358 cells, 1uM dab…
- GSM8378101 NCI-H358 cells, 1uM dabrafenib, 4 hours, rep4 NCI-H358 cells, 1uM dab…
- GSM8378102 NCI-H358 cells, 1uM dabrafenib & 30nM selumetinib, 4 hours, rep1 NCI-H358 cells, 1uM dab…
- GSM8378103 NCI-H358 cells, 1uM dabrafenib & 30nM selumetinib, 4 hours, rep2 NCI-H358 cells, 1uM dab…
- GSM8378104 NCI-H358 cells, 1uM dabrafenib & 30nM selumetinib, 4 hours, rep3 NCI-H358 cells, 1uM dab…
- GSM8378105 NCI-H358 cells, 1uM dabrafenib & 30nM selumetinib, 4 hours, rep4 NCI-H358 cells, 1uM dab…
- GSM8378106 NCI-H358 cells, 30nM selumetinib, 4 hours, rep1 NCI-H358 cells, 30nM se…
- GSM8378107 NCI-H358 cells, 30nM selumetinib, 4 hours, rep2 NCI-H358 cells, 30nM se…
- GSM8378108 NCI-H358 cells, 30nM selumetinib, 4 hours, rep3 NCI-H358 cells, 30nM se…
- GSM8378109 NCI-H358 cells, 30nM selumetinib, 4 hours, rep4 NCI-H358 cells, 30nM se…
- GSM8378110 NCI-H358 cells, DMSO, 24 hours, rep1 NCI-H358 cells, DMSO, 2…
- GSM8378111 NCI-H358 cells, DMSO, 24 hours, rep2 NCI-H358 cells, DMSO, 2…
- GSM8378112 NCI-H358 cells, DMSO, 24 hours, rep3 NCI-H358 cells, DMSO, 2…
- GSM8378113 NCI-H358 cells, DMSO, 24 hours, rep4 NCI-H358 cells, DMSO, 2…
- GSM8378114 NCI-H358 cells, 1uM dabrafenib, 24 hours, rep1 NCI-H358 cells, 1uM dab…
- GSM8378115 NCI-H358 cells, 1uM dabrafenib, 24 hours, rep2 NCI-H358 cells, 1uM dab…
- GSM8378116 NCI-H358 cells, 1uM dabrafenib, 24 hours, rep3 NCI-H358 cells, 1uM dab…
- GSM8378117 NCI-H358 cells, 1uM dabrafenib, 24 hours, rep4 NCI-H358 cells, 1uM dab…
- GSM8378118 NCI-H358 cells, 1uM dabrafenib & 30nM selumetinib, 24 hours, rep1 NCI-H358 cells, 1uM dab…
- GSM8378119 NCI-H358 cells, 1uM dabrafenib & 30nM selumetinib, 24 hours, rep2 NCI-H358 cells, 1uM dab…
- GSM8378120 NCI-H358 cells, 1uM dabrafenib & 30nM selumetinib, 24 hours, rep3 NCI-H358 cells, 1uM dab…
- GSM8378121 NCI-H358 cells, 1uM dabrafenib & 30nM selumetinib, 24 hours, rep4 NCI-H358 cells, 1uM dab…
- GSM8378122 NCI-H358 cells, 30nM selumetinib, 24 hours, rep1 NCI-H358 cells, 30nM se…
- GSM8378123 NCI-H358 cells, 30nM selumetinib, 24 hours, rep2 NCI-H358 cells, 30nM se…
- GSM8378124 NCI-H358 cells, 30nM selumetinib, 24 hours, rep3 NCI-H358 cells, 30nM se…
- GSM8378125 NCI-H358 cells, 30nM selumetinib, 24 hours, rep4 NCI-H358 cells, 30nM se…
- GSE104244 Bone Marrow Derived Macrophages, NSCLC cell lines, and Kras G12D Lung Tumors Treated with Epigenetic Agents 33 samples same disease briefing · shares nsclc, kras, line
- GSE117570 Reprogramming of Tumor-infiltrating Immune Cells in Early Stage of NSCLC 8 samples same disease briefing · shares nsclc
- GSE27389 Substitutions in the KRas oncogene determine protein behavior: Implications for signaling and clinical outcome. 22 samples same disease briefing · shares kras
- GSE127465 Single cell transcriptomics of human and mouse lung cancers reveals conserved myeloid populations across individuals and species 40 samples same disease briefing
- GSE103550 Lung Cancer Cell-Mediated Skeletal Muscle Mitochondrial Dysfunction is Mitigated by 1a,25-Dihydroxyvitamin D3 24 samples same disease briefing
- GSE241518 High-throughout sequencing of colorectal cancer and non-small cell lung cancer cells treated actived compound YHM18 4 samples same disease briefing
- GSE10072 Gene expression signature of cigarette smoking and its role in lung adenocarcinoma development and survival 107 samples same disease briefing
- GSE17958 Affymetrix SNP array data for 47 lung squamous cell carcinoma and 40 esophageal squamous cell carcinoma samples. 87 samples same disease briefing
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.